Structure-Activity Relationship Study of N6-Benzoyladenine-Type BRD4 Inhibitors and Their Effects on Cell Differentiation and TNF-α Production

被引：10

作者：

Amemiya, Seika ^{[1
]}

Yamaguchi, Takao ^{[1
]}

Sakai, Taki ^{[1
]}

Hashimoto, Yuichi ^{[1
]}

Noguchi-Yachide, Tomomi ^{[1
]}

机构：

[1] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan

来源：

CHEMICAL & PHARMACEUTICAL BULLETIN | 2016年 / 64卷 / 09期

关键词：

bromodomain; bromodomain and extra-terminal domain (BET); BRD4; cell differentiation; tumor necrosis factor (TNF)-alpha; BROMODOMAIN PROTEIN BRD4; NF-KAPPA-B; P-TEFB; C-MYC; LEUKEMIA; RECOGNITION; THALIDOMIDE; RELEASE; TARGET;

D O I：

10.1248/cpb.c16-00410

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Bromodomains are epigenetic 'readers' of histone acetylation. The first potent bromodomain and extra terminal domain (BET) inhibitors, (+)-JQ1 and I-BET762 (also known as GSK525762), were reported in 2010. Some BET inhibitors are already under clinical trial for the treatment of cancers, but so far, only a few chemical scaffolds are available. We have reported potent N-6-benzoyladenine-based inhibitors of BRD4, a BET family member that serves as a key mediator of transcriptional elongation. Here we present an analysis of the structure activity relationships of these inhibitors. Among the compounds examined, 20, 28 and 29 enhanced all-trans retinoic acid (ATRA)-induced HL-60 cell differentiation and inhibited tumor necrosis factor (TNF)-alpha production by THP-1 cells.

引用

页码：1378 / 1383

页数：6

共 25 条

[11] Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors [J].

Lee, Heehyoung ;

Herrmann, Andreas ;

Deng, Jie-Hui ;

Kujawski, Maciej ;

Niu, Guilian ;

Li, Zhiwei ;

Forman, Steve ;

Jove, Richard ;

Pardoll, Drew M. ;

Yu, Hua .

CANCER CELL, 2009, 15 (04) :283-293

[12] Tumor necrosis factor-alpha production-inhibiting activity of phthalimide analogues on human leukemia THP-1 cells and a structure-activity relationship study [J].

Miyachi, H ;

Ogasawara, A ;

Azuma, A ;

Hashimoto, Y .

BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (11) :2095-2102

[13]

NAKAJIMA O, 1994, BIOL PHARM BULL, V17, P742

[14] Suppression of inflammation by a synthetic histone mimic [J].

Nicodeme, Edwige ;

Jeffrey, Kate L. ;

Schaefer, Uwe ;

Beinke, Soren ;

Dewell, Scott ;

Chung, Chun-wa ;

Chandwani, Rohit ;

Marazzi, Ivan ;

Wilson, Paul ;

Coste, Herve ;

White, Julia ;

Kirilovsky, Jorge ;

Rice, Charles M. ;

Lora, Jose M. ;

Prinjha, Rab K. ;

Lee, Kevin ;

Tarakhovsky, Alexander .

NATURE, 2010, 468 (7327) :1119-1123

[15] Cell differentiation inducers derived from thalidomide [J].

Noguchi, T ;

Miyachi, H ;

Katayama, R ;

Naito, M ;

Hashimoto, Y .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (13) :3212-3215

[16] Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors [J].

Noguchi-Yachide, Tomomi ;

Sakai, Taki ;

Hashimoto, Yuichi ;

Yamaguchi, Takao .

BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (05) :953-959

[17]

Pasparakis Manolis, 1996, Cytokine and Growth Factor Reviews, V7, P223, DOI 10.1016/S1359-6101(96)00031-7

[18] 9H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain [J].

Picaud, Sarah ;

Strocchia, Maria ;

Terracciano, Stefania ;

Lauro, Gianluigi ;

Mendez, Jacqui ;

Daniels, Danette L. ;

Riccio, Raffaele ;

Bifulco, Giuseppe ;

Bruno, Ines ;

Filippakopoulos, Panagis .

JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (06) :2718-2736

[19] c-Myc Regulates Transcriptional Pause Release [J].

Rahl, Peter B. ;

Lin, Charles Y. ;

Seila, Amy C. ;

Flynn, Ryan A. ;

McCuine, Scott ;

Burge, Christopher B. ;

Sharp, Phillip A. ;

Young, Richard A. .

CELL, 2010, 141 (03) :432-445

[20] Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors [J].

Romero, F. Anthony ;

Taylor, Alexander M. ;

Crawford, Terry D. ;

Tsui, Vickie ;

Cote, Alexandre ;

Magnuson, Steven .

JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (04) :1271-1298

← 1 2 3 →